<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines | Just for your understanding</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    
  </head>

  <body>
    <nav>
    <ul class="menu">
      
      <li><a href="/">Home</a></li>
      
      <li><a href="/about/">About</a></li>
      
      <li><a href="/categories/">Categories</a></li>
      
      <li><a href="/tags/">Tags</a></li>
      
      <li><a href="/index.xml">Subscribe</a></li>
      
    </ul>
    <hr/>
    </nav>

<div class="article-meta">
<h1><span class="title">High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines</span></h1>
<h2 class="author">zijian</h2>
<h2 class="date">2020/04/06</h2>
</div>

<main>



<div id="title" class="section level1">
<h1>Title</h1>
<blockquote>
<p>High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines</p>
</blockquote>
</div>
<div id="citaion" class="section level1">
<h1>Citaion</h1>
<blockquote>
<p>Yu C, Mannan AM, Yvone GM, et al. High-throughput identification of genotype-specific cancer vulnerabilities in &gt;mixtures of barcoded tumor cell lines. Nat Biotechnol. 2016;34(4):419–423. <a href="doi:10.1038/nbt.3460" class="uri">doi:10.1038/nbt.3460</a></p>
</blockquote>
</div>
<div id="abstract" class="section level1">
<h1>Abstract</h1>
<blockquote>
<p>Hundreds of genetically characterized cell lines are available for the discovery of genotype-specific cancer &gt;vulnerabilities. However, screening large numbers of compounds against large numbers of cell lines is currently &gt;impractical, and such experiments are often difficult to control1-4. Here, we report a method called PRISM that allows &gt;pooled screening of mixtures of cancer cell lines by labeling each cell line with 24-nucleotide barcodes. PRISM &gt;displayed the expected patterns of cell killing seen in conventional (unpooled) assays. In a screen of 102 cell lines &gt;across 8,400 compounds, PRISM led to the identification of BRD-7880 as a potent and highly specific inhibitor of aurora &gt;kinases B and C. Cell line pools also efficiently formed tumors as xenografts, and PRISM recapitulated the expected &gt;pattern of erlotinib sensitivity in vivo</p>
</blockquote>
</div>
<div id="take-home-message" class="section level1">
<h1>Take home Message</h1>
<blockquote>

</blockquote>
</div>

</main>

  <footer>
  <script src="//yihui.name/js/math-code.js"></script>
<script async src="//cdn.bootcss.com/mathjax/2.7.1/MathJax.js?config=TeX-MML-AM_CHTML"></script>

<script async src="//yihui.name/js/center-img.js"></script>

  
  <hr/>
  © <a href="https://zijzhang.netlify.com">Zijian Zhang</a> 2018 &ndash; 2019 | <a href="https://github.com/zijzhang">Github</a>
  
  </footer>
  </body>
</html>

